---
schema_version: "secwatch.filing_event.v1"
accession: "0001178913-26-000244"
form_type: "8-K"
ticker: "LFWD"
cik: "0001607962"
company_name: "Lifeward Ltd."
filed_at: "2026-01-28T23:59:59+00:00"
generated_at: "2026-05-16T07:01:07.950470+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Lifeward schedules March 12 meeting to vote on Oratech acquisition from Oramed; board to expand to 8

## Summary
- EGM on March 12, 2026 to approve issuance of shares to Oramed as consideration for acquiring all of Oratech.
- Upon closing, board to consist of 8 members: 3 from Lifeward, 3 from Oramed, and 2 external directors.
- Oramed would hold at least 45% (potentially >49.99%) of voting power, triggering change-of-control rules.
- Other proposals: election of external directors, increase in 2025 incentive plan shares, CEO equity grant, auditor reappointment.
- Definitive proxy statement expected to be filed on or about February 9, 2026.

## SEC filing metadata
- accession: 0001178913-26-000244
- form_type: 8-K
- ticker: LFWD
- cik: 0001607962
- company_name: Lifeward Ltd.
- filed_at: 2026-01-28T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 5.02, 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1607962/000117891326000244/0001178913-26-000244-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1607962/000117891326000244/zk2634263.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001178913-26-000244
- JSON: https://secwatch.observer/filing/0001178913-26-000244.json
- Plain text: https://secwatch.observer/filing/0001178913-26-000244.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.